John S. Hollinsworth - 14 Nov 2023 Form 4 Insider Report for Acadia Healthcare Company, Inc. (ACHC)

Role
EVP of Operations
Signature
/s/ Brian Farley as Attorney in Fact for John S. Hollinsworth
Issuer symbol
ACHC
Transactions as of
14 Nov 2023
Net transactions value
-$6,846,300
Form type
4
Filing time
16 Nov 2023, 17:01:06 UTC
Previous filing
13 Nov 2023
Next filing
01 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACHC Common Stock Sale $1,110,000 -15,000 -8.5% $74.00 162,130 14 Nov 2023 Direct
transaction ACHC Common Stock Sale $1,104,900 -15,000 -9.3% $73.66 147,130 14 Nov 2023 Direct F1
transaction ACHC Common Stock Sale $1,102,650 -15,000 -10% $73.51 132,130 14 Nov 2023 Direct F2
transaction ACHC Common Stock Sale $1,480,000 -20,000 -15% $74.00 112,130 14 Nov 2023 Direct
transaction ACHC Common Stock Sale $2,048,750 -27,500 -25% $74.50 84,630 14 Nov 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.5506 to $73.81, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.50 to $73.68, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.50 to $74.51, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.